What is the appropriate dose, administration technique, and contraindications for intra‑articular ketorolac (Toradol) for short‑term relief of acute joint pain in an adult without NSAID allergy, renal insufficiency, peptic ulcer disease, or bleeding diathesis?

Intra-articular Ketorolac for Acute Joint Pain

Intra-articular ketorolac is a viable alternative to corticosteroid injection for acute joint pain, with doses of 5-30 mg diluted in local anesthetic providing equivalent pain relief and functional improvement to corticosteroids, while avoiding steroid-related complications.

Dosing and Administration

The evidence supports the following approach for intra-articular ketorolac:

Recommended dose: 5-30 mg ketorolac mixed with local anesthetic (typically 0.5% lidocaine 4-20 mL depending on joint size) 1, 2, 3.

• Small joints (knee): 5 mg ketorolac in 20 mL of 0.5% bupivacaine provides equivalent analgesia to 10 mg IV ketorolac 3
• Large joints (hip, shoulder): 30 mg ketorolac in 1 mL mixed with 19-20 mL of 0.5% lidocaine has demonstrated efficacy comparable to triamcinolone 40 mg 1, 2

Technique and Safety Requirements

Following EULAR 2021 guidelines for intra-articular therapies 4:

• Aseptic technique is mandatory for all intra-articular injections
• Ultrasound guidance improves accuracy and should be used when available, particularly for hip and shoulder injections 1, 2
• Patient positioning on examination table with ability to lie flat
• Resuscitation equipment should be nearby
• Consider offering local anesthetic at injection site (explain pros/cons to patient)

Critical safety point: Do not inject unless appropriate diagnosis is established and contraindications are ruled out 4.

Efficacy Evidence

Multiple studies demonstrate non-inferiority of intra-articular ketorolac compared to corticosteroids:

• Hip osteoarthritis: Ketorolac showed equivalent improvement in Harris hip scores and pain scales at 1,3, and 6 months compared to triamcinolone, with no statistical differences 1
• Frozen shoulder: Ketorolac with capsular distension provided similar pain relief and functional improvement as steroid injection alone, with superior improvement in passive range of motion (abduction and external rotation) at 3 and 6 months 2
• Post-arthroscopy pain: Low-dose intra-articular ketorolac (5 mg) provided similar analgesia to higher systemic doses 3

Absolute Contraindications

Based on systemic ketorolac safety data 5, 6:

• Active or history of gastrointestinal bleeding or peptic ulcer disease
• Current risk of renal failure or compromised renal function
• Compromised hemostasis or bleeding disorders
• Hypersensitivity to aspirin or other NSAIDs
• Pregnancy, labor, delivery, or breastfeeding
• Advanced age (>65 years requires extreme caution)

Important caveat: While the EULAR guideline states that intra-articular therapy is not contraindicated in patients with clotting/bleeding disorders unless bleeding risk is high 4, systemic ketorolac carries platelet dysfunction risks 5, 6. Use extreme caution in patients on anticoagulants or with hemostatic compromise.

Duration and Frequency

• Limit treatment duration to ≤5 days if repeated injections considered 5
• Avoid overuse of injected joint for 24 hours, but immobilization is discouraged 4
• Reinject only after 3 months minimum if considering repeat injection, and only if previous injection provided benefit 4

Advantages Over Corticosteroids

Ketorolac may be preferred when 1, 7:

• Patient has contraindications to corticosteroids (diabetes, immunosuppression, concern for cartilage breakdown)
• Avoiding systemic steroid effects is priority
• Multiple injections anticipated (reduced risk of cartilage damage and infection compared to repeated steroid injections)

Clinical Context from Guidelines

The 2020 ACP/AAFP guideline for acute musculoskeletal pain recommends topical NSAIDs as first-line therapy and oral NSAIDs as second-line for non-low back musculoskeletal injuries 8. While this guideline does not specifically address intra-articular ketorolac, it establishes NSAIDs as preferred over opioids for acute musculoskeletal pain management, supporting the rationale for intra-articular NSAID use.

Practical Algorithm

1. Confirm diagnosis and rule out infection or other contraindications
2. Screen for contraindications: GI bleeding history, renal insufficiency, NSAID allergy, pregnancy, age >65
3. Prepare: Aseptic technique, ultrasound guidance if available
4. Dose selection: 5-30 mg ketorolac based on joint size, mixed with 4-20 mL local anesthetic
5. Inject using sterile technique under ultrasound guidance
6. Advise: Avoid overuse for 24 hours, no immobilization
7. Monitor: Assess response at 1-3 months before considering repeat injection